The relationship between the gut microbiome and #GvHD is a fascinating topic in the field of transplantation. @ErnstHoller of @uni_regensburg provides valuable insight in a recent interview from #EBMT24: 👉 ow.ly/6gjj50Rvx1s #BMTsm #HemOnc @TheEBMT

#mmsm #lymsm #leusm #bmtsm #mdsm #mpnsm #bcsm #crcsm #prostatecancer #CancerResearch

More grade 3-5 AEs in ibrutinib-containing arms during induction/ASCT, especially infections (left). Way more grade 3-5 AEs in A+I arm during maintenance (right), especially cytopenias & infections. Definitely higher toxicity of ibrutinib maintenance after ASCT. #lymsm #bmtsm

keyboard_arrow_left Previous keyboard_arrow_right Next

Quick review of the TRIANGLE data, *finally* published @TheLancet: randomized phase 3 trial of ibrutinib + induction chemo +/- ASCT in first-line mantle cell lymphoma. 🧵#lymsm #bmtsm thelancet.com/journals/lance…

#Hematology Ibrutinib combined with CIT with or without autologous stem-cell transplantation #ASCT vs CIT and autologous stem-cell transplantation in previously untreated patients with mantle cell #lymphoma (TRIANGLE) #lymsm #bmtsm thelancet.com/journals/lance…

@GuiperiniMD #MCLsm #lymsm #bmtsm

BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 ash.confex.com/ash/2022/webpr… #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients [Nov 25, 2021] Mariano Arribas et al. @Rfonsi1 @AjHematology onlinelibrary.wiley.com/doi/full/10.10… #mmsm #bmtsm #IDonc HT @RahulBanerjeeMD

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a Ph3 RCT & post-hoc efficacy analysis [Aug 6, 2019] Dagnew et al. @TheLancetInfDis ow.ly/LBaw30qoLOX #NCT01767467 #IDonc #mmsm #leusm #lymsm #bmtsm

keyboard_arrow_left Previous keyboard_arrow_right Next

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial [Jul 9, 2019] Bastidas et al. @JAMA_current ow.ly/uQKt30p6mcC #IDonc #bmtsm #NCT01610414 HT @drkomanduri 68.2% vaccine efficacy

Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study [Sep 15, 2018] Piñana et al. @Infectdispract ow.ly/DnQX30pT6Nt #IDonc #bmtsm #Flu

MT @EagleMyeloma [Feb 11, 2018] Live virus vaccines now safe 2+ years after autologous stem cell transplant in myeloma patients. Don't know whether it works. Even if it works, is MMR useful in myleoma? #mmsm #bmtsm RE: Pandit et al. BMT ncbi.nlm.nih.gov/pubmed/29426830

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance [Dec 27, 2017] Palazzo et al. @DrMiguelPerales BBMT ow.ly/iLIO30oZZ5q #mmsm #IDonc #bmtsm HT @MSKHemOncTrials

Initiative helps ensure patients receive necessary vaccinations post-aHSCT [May 9, 2017] @JournalofCP ow.ly/3fyl30bBx9D #bmtsm #IDonc

Myeloma 101: Vaccinations After Myeloma Stem Cell Transplant [May 8, 2017] Paul Kleutghen @MyelomaCrowd ow.ly/35c630pCPpT #mmsm #bmtsm #IDonc

Tracking Immunizations Can Improve Post-HSCT Vaccination Rates [May 4, 2017] Furlow #ONSCongress @CancerNetwrk ow.ly/Qtc630bta1Z #bmtsm #IDonc

Re-Vaccination Following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance [Apr 2017] Palazzo et al. Biology of Blood and Marrow Transplantation ow.ly/D55O30pHV9u #mmsm #bmtsm #IDonc

Timing of influenza vaccine response in patients that receive autologous hematopoietic cell transplantation [Mar 2017] Sokol et al. BBMT ; 23: S143–S144 ow.ly/1kKm30p01ux #bmtsm #mmsm #ImmunoOnc #IDonc 11/24 (46%) FV responders

Vaccination after Stem Cell Transplant [7/2016] Bryan Tutt @MDAndersonNews ow.ly/ZNPt302XCmP #ImmunoOnc #bmtsm #mmsm #lymsm #leusm #IDonc